Skip to content
Open access

FlexAutoDock: A Flexible Platform for Automated Molecular Docking and Virtual Screening of Natural and Synthetic Compounds

Aug 2026 · bioRxiv · 0 citations · 34 references
Biology

TL;DR

FlexAutoDock is an automated cloud-based molecular docking platform that provides a unified environment for protein-ligand docking and large-scale virtual screening, providing researchers with an accessible computational resource for accelerating early-stage drug discovery.

Abstract

Drug discovery (DD) is a complex, time-consuming, and resource-intensive process that involves the identification of therapeutic targets, selection of bioactive compounds, and extensive experimental validation. The discovery of promising therapeutic compounds from large libraries of phytochemicals and synthetic molecules remains a major challenge in modern drug development. Screening millions of compounds through conventional experimental approaches requires substantial time, cost, and computational resources. In recent years, in- silico molecular docking has emerged as an important computational approach for predicting interactions between small molecules and target proteins, thereby helping researchers prioritize promising compounds for further investigation. Several molecular docking webservers, including iScreen, SwissDock, CB-Dock2, DockThor, and MTiOpenScreen, have been developed to support virtual screening studies. However, many currently available platforms still face some important limitations. Most existing tools lack integrated repositories of medicinal plant-derived phytochemicals and organism-derived bioactive compounds, automated mapping between plants and their associated phytochemicals, and flexible ligand retrieval using chemical names, SMILES strings, PubChem CIDs, or drug names. In addition, many platforms require extensive manual protein and ligand preparation, provide limited support for AlphaFold-predicted protein structures, and lack efficient large-scale multi-target virtual screening. Most existing docking platforms offer limited support for interactive inspection of docked protein-ligand complexes, often requiring users to download the results and analyse them using external molecular visualization software. To address these limitations, we developed FlexAutoDock, an automated cloud-based molecular docking platform that provides a unified environment for protein-ligand docking and large-scale virtual screening. Unlike existing web servers, FlexAutoDock integrates curated repositories of medicinal plant- derived phytochemicals, organism-derived bioactive compounds, and synthetic compounds from the ZINC database while supporting flexible ligand acquisition through medicinal plant or organism selection, chemical names, SMILES strings, PubChem CIDs, and drug-name queries. The platform further streamlines the docking workflow through automated protein structure retrieval from the Protein Data Bank and AlphaFold databases, receptor and ligand preparation, chain-specific protein selection, blind and site-specific docking, interactive visualization of predicted protein-ligand complexes, and scalable multi-target virtual screening. The resulting platform enables rapid, flexible, and large-scale virtual screening while simplifying the molecular docking workflow, providing researchers with an accessible computational resource for accelerating early-stage drug discovery. FlexAutoDock offers a fast, reliable, and accessible computational platform for molecular docking and virtual screening, freely available to the scientific community at http://103.99.177.82:3000/.

Read PDF

Similar papers

Review Open access Jul 2026

Natural Products in Modern Drug Discovery: Advances, Challenges and Emerging Technologies

A comprehensive and mechanistic overview of natural products as lead compounds, emphasizing their chemical characteristics, biological relevance, sources, mechanisms of action, and integration into modern drug discovery pipelines is provided.

Souzana K. Papadopoulou, Efthymios Poulios, Fotios Tsopelas et al. · 2 citations
Sep 2026

Performances and Critical Limitations of Docking and Protein–Ligand Interactions for Efficacy-Driven Virtual Screening Targeting Class A GPCRs

A comprehensive assessment based on systematic benchmarking using a diverse set of class A G-protein-coupled receptors and different approaches to represent protein–ligand demonstrates that the combined approach overall improves the efficacy bias of selected ligands as compared to docking alone.

Luca Chiesa, G. Bret, Severine Schneider et al. · 0 citations
Open access Jul 2026

Prioritizing neuroactive ligands using motif-guided virtual discovery and zebrafish profiling

Rosetta Engine for Anchoring Ligands with a Motif is introduced, a screening algorithm that uses structural interaction data from the Protein Data Bank to guide ligand placement and selection and is readily adaptable to the thousands of zebrafish proteins with highly conserved binding pockets.

Ari B. Ginsparg, Jaqueline A. Martinez, Ishaan Patel et al. · 0 citations
Open access Sep 2026

An extension of jamdock-suite for virtual screening from raw chemical datasets

Semdock is presented, an extension of the original workflow that enables the preparation of docking-ready ligands from raw SDF, SMILES, and CSV datasets through an automated ligand preparation procedure and implements ligand-wise CPU-parallel docking.

Shahariar Emon, M. Haque, Iftekhar Alam et al. · 0 citations
Open access Aug 2026

A Comprehensive Study Utilizing QSAR, Virtual Screening, Molecular Docking, Molecular Dynamics, and MM/GBSA Analyses Reveals Natural Diterpenoids as Promising Caspase-1 Inhibitors

This study highlights natural diterpenoids and coumarin glycosides as promising scaffolds for caspase-1 inhibition and demonstrates that integrating QSAR modeling with structure-based approaches provides an efficient strategy for discovering potential anti-inflammatory drug candidates.

Yusuf Şeflekçi, Alper Yılmaz, Abdulilah Ece · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.